Drug Firm Apotex Seeks Valuation Over C$5 Billion in Canada IPO
· Financial Post
(Bloomberg) — Canadian drug manufacturer Apotex Health Corp. and its shareholders are looking to raise as much as C$1.15 billion (about $830 million) in an initial public offering, at a valuation that would mean a healthy profit for SK Capital Partners. Read More
Visit palladian.co.za for more information.